Daniel Grosslight
Stock Analyst at Citigroup
(1.06)
# 3,602
Out of 4,843 analysts
94
Total ratings
30.51%
Success rate
-15%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $56.56 | -46.96% | 11 | May 6, 2025 | |
| HCAT Health Catalyst | Maintains: Buy | $7 → $6.5 | $3.80 | +71.05% | 9 | Apr 25, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $11 → $8.75 | $6.92 | +26.45% | 11 | Apr 25, 2025 | |
| AGL agilon health | Upgrades: Buy | $3.25 → $5 | $2.22 | +125.23% | 5 | Apr 25, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $13 → $11 | $6.60 | +66.67% | 6 | Apr 17, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $120 → $129 | $154.44 | -16.47% | 5 | Jan 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $7.45 | +141.61% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $3.92 | +59.44% | 7 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $719.51 | -5.91% | 7 | Jan 10, 2025 | |
| PHR Phreesia | Maintains: Buy | $31 → $35 | $24.49 | +42.92% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $22.76 | +9.84% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $4.10 | +143.90% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $10.20 | -21.57% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $2.17 | -42.40% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $3.19 | +9.72% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $8.95 | +45.25% | 1 | Dec 11, 2019 |
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $56.56
Upside: -46.96%
Health Catalyst
Apr 25, 2025
Maintains: Buy
Price Target: $7 → $6.5
Current: $3.80
Upside: +71.05%
Teladoc Health
Apr 25, 2025
Maintains: Neutral
Price Target: $11 → $8.75
Current: $6.92
Upside: +26.45%
agilon health
Apr 25, 2025
Upgrades: Buy
Price Target: $3.25 → $5
Current: $2.22
Upside: +125.23%
Owens & Minor
Apr 17, 2025
Maintains: Buy
Price Target: $13 → $11
Current: $6.60
Upside: +66.67%
Cardinal Health
Jan 10, 2025
Maintains: Neutral
Price Target: $120 → $129
Current: $154.44
Upside: -16.47%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $7.45
Upside: +141.61%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $3.92
Upside: +59.44%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $719.51
Upside: -5.91%
Phreesia
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $24.49
Upside: +42.92%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $22.76
Upside: +9.84%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $4.10
Upside: +143.90%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $10.20
Upside: -21.57%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $2.17
Upside: -42.40%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $3.19
Upside: +9.72%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $8.95
Upside: +45.25%